Safety and Tolerability of IBI355 in Healthy Volunteers

NCT06416787 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: placebo
DRUG: IBI355

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.